Composition
- Active ingredients
- CEFTRIAXONE SODIUM EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFTRIAXONE SODIUM EQ 500MG BASE/VIAL · InjectableANDA063239-002 · Discontinued
- CEFTRIAXONE SODIUM EQ 1GM BASE/VIAL · InjectableANDA063239-003 · Discontinued
- CEFTRIAXONE SODIUM EQ 250MG BASE/VIAL · InjectableANDA063239-001 · Discontinued
- CEFTRIAXONE SODIUM EQ 1GM BASE/VIAL · InjectableANDA062654-002 · Discontinued
- CEFTRIAXONE SODIUM EQ 2GM BASE/VIAL · InjectableANDA062654-003 · Discontinued
- CEFTRIAXONE SODIUM EQ 500MG BASE/VIAL · InjectableANDA062654-001 · Discontinued
- CEFTRIAXONE SODIUM EQ 500MG BASE/VIAL · InjectableANDA062510-002 · Discontinued
- CEFTRIAXONE SODIUM EQ 1GM BASE/VIAL · InjectableANDA062510-003 · Discontinued
- CEFTRIAXONE SODIUM EQ 250MG BASE/VIAL · InjectableANDA062510-001 · Discontinued
- CEFTRIAXONE SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050585-004 · Discontinued
- CEFTRIAXONE SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable
At a glance
- Brand name
- Rocephin
- Active substance
- ceftriaxone sodium
- Route
- Intramuscular, Intravenous
- Dosage form
- Injectable
- Applicant
- Hoffmann LA Roche
- Status
- Discontinued
- FDA approval
- 21 Dec 1984
- Application
- NDA050585-001